178 related articles for article (PubMed ID: 24509654)
1. CEA/CA72-4 levels in peritoneal lavage fluid are predictive factors in patients with gastric carcinoma.
Yamamoto M; Yoshinaga K; Matsuyama A; Tsutsui S; Ishida T
J Cancer Res Clin Oncol; 2014 Apr; 140(4):607-12. PubMed ID: 24509654
[TBL] [Abstract][Full Text] [Related]
2. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.
Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P
J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022
[TBL] [Abstract][Full Text] [Related]
3. CA72-4 antigen levels in serum and peritoneal washing in gastric cancer. Correlation with morphological aspects of neoplasia.
Fernandes LL; Martins LC; Nagashima CA; Nagae AC; Waisberg DR; Waisberg J
Arq Gastroenterol; 2007; 44(3):235-9. PubMed ID: 18060278
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.
Yamamoto M; Baba H; Toh Y; Okamura T; Maehara Y
J Cancer Res Clin Oncol; 2007 Jul; 133(7):471-6. PubMed ID: 17226046
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumor markers in peritoneal lavage in advanced gastric cancer.
Yamamoto M; Baba H; Kakeji Y; Endo K; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Maehara Y
Oncology; 2004; 67(1):19-26. PubMed ID: 15459491
[TBL] [Abstract][Full Text] [Related]
7. CA72-4 compared with carcinoembryonic antigen as a tumour marker for gastric cancer.
Hamazoe R; Maeta M; Matsui T; Shibata S; Shiota S; Kaibara N
Eur J Cancer; 1992; 28A(8-9):1351-4. PubMed ID: 1515249
[TBL] [Abstract][Full Text] [Related]
8. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
9. [CA72-4 and CEA in serum and peritoneal washing in gastric cancer].
Mandorwski S; Lourenço LG; Forones NM
Arq Gastroenterol; 2002; 39(1):17-21. PubMed ID: 12184160
[TBL] [Abstract][Full Text] [Related]
10. [Significance of CA72-4 as a follow up of recurrent gastric cancer--comparison with CEA and CA19-9].
Takahashi Y; Mai M
Gan To Kagaku Ryoho; 1992 Apr; 19(4):515-8. PubMed ID: 1558402
[TBL] [Abstract][Full Text] [Related]
11. The Detection of Messenger RNA for Carcinoembryonic Antigen and Cytokeratin 20 in Peritoneal Washing Fluid in Patients with Advanced Gastric Cancer.
Kim YJ; Chung WC; Choi S; Jung YD; Lee J; Chae SY; Jun KH; Chin HM
Korean J Gastroenterol; 2017 Apr; 69(4):220-225. PubMed ID: 28449423
[TBL] [Abstract][Full Text] [Related]
12. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
13. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
Yin LK; Sun XQ; Mou DZ
Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer.
Nishiyama M; Takashima I; Tanaka T; Yoshida K; Toge T; Nagata N; Iwamori S; Tamura Y
World J Surg; 1995; 19(1):133-7; discussion 137. PubMed ID: 7740800
[TBL] [Abstract][Full Text] [Related]
15. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA.
Kodama I; Koufuji K; Kawabata S; Tetsu S; Tsuji Y; Takeda J; Kakegawa T
Int Surg; 1995; 80(1):45-8. PubMed ID: 7657491
[TBL] [Abstract][Full Text] [Related]
16. The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy.
Kim DH; Oh SJ; Oh CA; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
J Surg Oncol; 2011 Nov; 104(6):585-91. PubMed ID: 21695697
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination.
Emoto S; Ishigami H; Yamashita H; Yamaguchi H; Kaisaki S; Kitayama J
Gastric Cancer; 2012 Apr; 15(2):154-61. PubMed ID: 21892754
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of CA72-4 as a tumor marker in patients with gastric cancer].
Ubukata H; Katano M; Motohashi G; Kasuga T; Takemura A; Tabuchi T; Tabuchi T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1821-4. PubMed ID: 14619529
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of CEA/CA72-4 immunohistochemistry in combination with cytology for detecting tumor cells in peritoneal lavage in gastric cancer.
Qu L; He L; Jia Z; Wang Q
J Cancer; 2020; 11(21):6319-6325. PubMed ID: 33033515
[No Abstract] [Full Text] [Related]
20. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
